Research

10/11/18

Research by John J. Leddy, MD, clinical assistant professor of orthopaedics, and Barry S. Willer, PhD, professor of psychiatry, did not find evidence of early-onset dementia (EOD) in a study of retired National Football League and National Hockey League players.

8/27/18

Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified a new drug target for remyelination in multiple sclerosis (MS).

8/3/18

Researchers at the Hunter James Kelly Research Institute (HJKRI) have been awarded a pair of grants for the investigation of mechanisms underlying axonal degeneration in certain neurological disorders.

7/30/18

Newly published research led by Robert Zivadinov, MD, PhD, professor of neurology, finds novel indicators for predicting worsening conditions in multiple sclerosis (MS) patients.

5/8/18

Vincent M. Tutino, PhD, a recent graduate of the doctoral program in biomedical engineering, is first author on a published study in PLOS ONE showing that circulating cells in the blood carry a gene expression “signature” that may predict if someone has a brain aneurysm. 

3/28/18

Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, that seeks to spur development of cellular and molecular therapies for adult demyelinating disease, such as multiple sclerosis, has gained funding from the National Institutes of Health.

3/22/18

A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.

3/21/18

The National Multiple Sclerosis Society (NMSS) has given its Impact Award to Bianca Weinstock-Guttman, MD, professor of neurology, a widely known leading expert on multiple sclerosis (MS) in adults and children.

2/15/18

The National Multiple Sclerosis Society (NMSS) has funded two separate projects led by researchers in the departments of Neurology and Pharmacology and Toxicology.